Zealand Pharma sells rusfertide royalty rights to Royalty Pharma for $100M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to Zealand Pharma sells rusfertide royalty rights to Royalty Pharma for $100M
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 58.44 +0.03 (0.05%)
Previous Close $58.41    52 Week High $3.48 
Open $58.56    52 Week Low $0.80 
Day High $59.07    P/E N/A 
Day Low $57.82    EPS $-1.54 
Volume 3,231,941       

(NASDAQ: ZEAL) Delayed: 17.59 --0 (-0%)
Previous Close $17.59    52 Week High $ 
Open $1.35    52 Week Low $ 
Day High $17.59    P/E N/A 
Day Low $17.59    EPS $ 
Volume 15,962